111 related articles for article (PubMed ID: 1646127)
1. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.
du Toit RS; Locker AP; Ellis IO; Elston CW; Nicholson RI; Robertson JF; Blamey RW
Eur J Surg Oncol; 1991 Jun; 17(3):251-7. PubMed ID: 1646127
[TBL] [Abstract][Full Text] [Related]
2. [Special clinical and follow-up aspects of invasive lobular breast cancer].
Mitze M; Meyer F; Goepel E; Kleinkauf-Houcken A; Jonat W
Geburtshilfe Frauenheilkd; 1991 Dec; 51(12):973-9. PubMed ID: 1794684
[TBL] [Abstract][Full Text] [Related]
3. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.
Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K
Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
Dixon AR; Ellis IO; Elston CW; Blamey RW
Br J Cancer; 1991 Apr; 63(4):634-5. PubMed ID: 1850613
[TBL] [Abstract][Full Text] [Related]
5. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
[TBL] [Abstract][Full Text] [Related]
6. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
7. Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors.
DiCostanzo D; Rosen PP; Gareen I; Franklin S; Lesser M
Am J Surg Pathol; 1990 Jan; 14(1):12-23. PubMed ID: 2153007
[TBL] [Abstract][Full Text] [Related]
8. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
Korhonen T; Kuukasjärvi T; Huhtala H; Alarmo EL; Holli K; Kallioniemi A; Pylkkänen L
Breast; 2013 Dec; 22(6):1119-24. PubMed ID: 23863867
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
10. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
11. [Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases].
Hauser H; Beham A; Steindorfer P; Smola MG; Fruhwirth H; Klimpfinger M
Wien Klin Wochenschr; 1992; 104(23):717-20. PubMed ID: 1335634
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
Fondrinier E; Guérin O; Lorimier G
Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
[TBL] [Abstract][Full Text] [Related]
13. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
14. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing survival in infiltrating lobular carcinoma of the breast.
Sariego J; Byrd M; Kerstein M; Matsumoto T
Am Surg; 1993 Jul; 59(7):405-9. PubMed ID: 8391768
[TBL] [Abstract][Full Text] [Related]
16. Breast conservative surgery and local recurrence.
Rezai M; Kraemer S; Kimmig R; Kern P
Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
[TBL] [Abstract][Full Text] [Related]
17. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
18. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
19. [Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers].
Horst HA; Horny HP; Gent HJ; Sellschopp C; Hedderich J
Klin Wochenschr; 1988 Dec; 66(23):1160-6. PubMed ID: 2850408
[TBL] [Abstract][Full Text] [Related]
20. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
